COMP <GO>
BHVN vs MBX // FREE CASH FLOW YIELD
Biohaven Ltd. (NYSE) VS. MBX Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: BHVN 2
— MBX 3
▲ FREE CASH FLOW YIELD LEADER: MBX
LAST: $15.42 (-6.49%) • MKT CAP: $2.49B
fcf-yield
-24.50%
LAST: $55.87 (+2.44%) • MKT CAP: $2.63B
fcf-yield
-3.12%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BHVN VS. MBX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BHVN | MBX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -26.40% | -8.60 | MBX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -24.50% | -3.12% | -21.38 | MBX | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | BHVN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.4 | 50.5 | +14.90 | BHVN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.49B | $2.63B | -$135.9M | MBX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BHVN REV | MBX REV | BHVN GROSS % | MBX GROSS % | BHVN FCF | MBX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$610.2M | -$81.9M |
| FY 2024 | $0 | $0 | — | — | -$586.5M | -$55.6M |
| FY 2023 | $0 | $0 | — | — | -$331.7M | -$32.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BHVN // BETA —
MBX // BETA —